登录新浪财经APP sōu索【信披】chágèng多考评děng

康芝药业:宏氏投资表示有足够履行回购义务的能力

5月28晚间,kāngzhīzàinián报问询函huízhōngbiǎoshìgēn控股股东hǎihóngshìtóuyǒuxiàngōngxià简称“hóngshìtóu”)签shǔdexiāng关协议,因zhōngshān爱护yòngpǐnyǒuxiàngōngxià简称“zhōngshān爱护”)未完chéng绩考核,hóngshìtóuhuígòuzhōngshān爱护100%dequánjīn额预估wèi59,000多wànyuánbāoběnjīn35,000wànyuán利息24,000多wànyuánhóngshìtóubiǎoshìbèiyǒuxínghuígòude能力。

gēnzhōngshěnzhònghuì师事所(特殊普通合伙rén)2024nián4月25de《关zhōngshān爱护yòngpǐnyǒuxiàngōng绩承诺完chéngkuàngshuō明专项shěn核报gào》,zhōngshān爱护2018nián、2019nián、2021nián、2022nián2023nián五个huìnián度累xiàn净利润(扣除非经常性损益qián后孰de归属gōng股东de净利润)wèi-9,896.45wànyuán,因其承诺jīn额17,215.6wànyuánde50%,gēnxiāng关协议tiáo款,目qiánhóngshìtóu已触huígòuzhōngshān爱护100%股quándehóngshìtóubiǎoshì其正zài尽快chùxiāng产,筹措jīnxínghuígòu

hóngshìtóubiǎoshìbèiyǒuxínghuígòude能力,其主要bāo括对外tóudehǎikāngtóuyǒuxiàngōngchíyǒu90%股quán,间接chíyǒuhǎichéng”商综合体,评估价zhíwèi7.49亿yuán(如hǎichéngtónghǎi甸岛de新商huá彩·hǎi口湾广chǎng”待售商wèi3.00wànyuán/平fāng,保shǒu按2.00wànyuán/平fāng预估,此zhí5.25亿yuán。);间接chíyǒuhǎikānglíng创意港tóuyǒuxiàngōng85.50%股quán,间接chíyǒuhǎikānglíng创意港二、办gōnggōng寓、tíngchǎngděngbèi案价算价zhíwèi5.40亿yuánděng。此外,hóngshìtóuxiàzigōng三亚kāng大国际yóuhángyǒuxiàngōng,目qiánbèi出售100%股quán,股quánràng价格约1700.00多wànyuán,xiàn已进入合tóngtiáozhōng交割细节沟通阶段,预nián6月zhōngxiàqián能完chéngquán交割。因此,hóngshìtóuwèigōnghánxiàzigōngchíyǒude主要产情kuàng,可zhènghóngshìtóuyǒudexínghuígòude能力。

kāngzhī称,截止běngōnggào披露gōng已收到hóngshìtóuláide《关绩承诺fānghǎihóngshìtóuyǒuxiàngōnghuígòukāngzhīfènyǒuxiàngōngchízhōngshān爱护yòngpǐnyǒuxiàngōng100%股quándefāngshuō明》。后续kāngzhījiāng积极绩承诺fānghóngshìtóuxíngxiāng,跟进绩承诺xíngkuàng,并xíngxiāngshěn批程序信息披露